NSE · AI Signal & Stock Analysis · Bearish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for AJANTPHARM is Bearish ↓ (moderate move); technical trend down-trend; trading at ₹3,464.80 (-1.60% today); neutral (RSI 44).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2026-09-01) |
| Price | ₹3,464.80 |
| Change today | -1.60% |
| RSI (14) | 44.00 |
| Relative volume | 0.53 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹44,051 Cr |
| P/E | 38.82 |
| Cap category | Large Cap |
| 52-week high | -6.8% away |
| 52-week low | +46.7% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for AJANTPHARM (Ajanta Pharma Limited) is Bearish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
AJANTPHARM's RSI is neutral (RSI 44). A reading above 70 is typically overbought and below 30 oversold.
AJANTPHARM is trading about 7% below its 52-week high and 47% above its 52-week low as of Sep 28 2026, 6:47 PM.
AJANTPHARM's market capitalisation is ₹44,051 Cr as of Sep 28 2026, 6:47 PM.
AJANTPHARM is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for AJANTPHARM — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AKUMS · ALIVUS · ALKEM · APLLTD
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.